About MedRhythms
MedRhythms is a private company based in Portland, Maine. It has reported $60,102,967 raised in nine offerings on Form D since July 2018.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Oct 13, 2026 | $250,000of $1.0M target | 1 | $250K | Debt, OptionsRule 506(b) | Form D ↗ |
| Jul 31, 2026 | Aug 7, 2026 | $1,000,000fully sold | 1 | $1.0M | Debt, OptionsRule 506(b) | Form D ↗ |
| Feb 13, 2026 | Mar 2, 2026 | $3,253,520of $5.8M target | 31 | $104K | EquityRule 506(b) | Form D ↗ |
| Mar 28, 2025 | Apr 3, 2025 | $2,880,559of $8.0M target | 3 | $960K | Debt, OptionsRule 506(b) | Form D ↗ |
| Nov 27, 2023 | Dec 12, 2023amended Jan 9, 2024 | $19,780,792of $26.2M target | 20 | $989K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 8, 2023 | Feb 22, 2023 | $5,823,569of $8.0M target | 6 | $970K | Debt, OptionsRule 506(b) | Form D ↗ |
| Jul 16, 2021 | Jul 28, 2021 | $20,935,092of $26.6M target | 23 | $910K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 8, 2019 | Aug 22, 2019 | $1,468,110of $3.0M target | 7 | $209K | EquityRule 506(b) | Form D ↗ |
| Jun 27, 2018 | Jul 11, 2018 | $4,711,325of $5.1M target | 14 | $336K | EquityRule 506(b) | Form D ↗ |
| Total, nine offerings | $60,102,967 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MedRhythms's Form D filed Oct 13, 2026.
Earlier filings also listed Peter Werth (director, last listed Mar 2026), Lawrence Jasinski (chief executive officer and director, last listed Mar 2026), Stephen Bruso (director, last listed Feb 2023), Ray Pawlicki (director, last listed Feb 2023) and Raymond Pawlicki (director, last listed Jul 2021).